Close Menu
Home » FDA Awards $2.4M to Vanderbilt Researcher for Duchenne Muscular Dystrophy Biomarker Study

FDA Awards $2.4M to Vanderbilt Researcher for Duchenne Muscular Dystrophy Biomarker Study

Oct 08, 2019
|
staff reporter

NEW YORK — The US Food and Drug Administration has awarded researchers from Vanderbilt University a roughly $2.4 million grant to identify genetic and other biomarkers that can be used to determine the severity and progression of cardiac dysfunction associated with Duchenne muscular dystrophy (DMD).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sweet Assembly

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Oh, You're Aging Well

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

Science Papers Describe MicroRNA Targeting Efficiency, Approach for Single-Cell High-Throughput Chemical Screens

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Dec
10
Featured Webinar

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

What's Popular?

In Biomarker Discovery & Validation

  1. Enpicom, Cytura Therapeutics to Develop Cancer Diagnostic

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.